QUANTRO Therapeutics
Business Services · Austria · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Dr. Bohr-gasse 7, Vienna, Vienna, 1030, ...Website
www.quantro-tx.comRevenue
<$5 MillionIndustry
About QUANTRO Therapeutics
Is QUANTRO Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at QUANTRO Therapeutics
Check out if QUANTRO Therapeutics is spiking on competitors!
Click to see if QUANTRO Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once QUANTRO Therapeutics has new funding data
Check if QUANTRO Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on QUANTRO Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
QUANTRO Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when QUANTRO Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
QUANTRO Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
QUANTRO Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about QUANTRO Therapeutics.
QUANTRO Therapeutics Tech Stack
A closer look at the technologies used by QUANTRO Therapeutics
Most Recent Scoops
QUANTRO Therapeutics News & Media
QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments
VIENNA, Austria, June 04, 2024 (GLOBE NEWSWIRE) -- QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced today that the company has reached a key milestone in its joint R&D program with Boehringer Ingelheim. In successfully applying QUANTRO’s proprietary QUANTROseq® Transcriptional Fingerprint technology, all pre-set goals for technical proof-of-concept, cross-validation of HTS screening technology and identificatQUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer
QUANTRO Therapeutics, an innovative drug discovery company focused on developing novel targeted therapeutics interfering with disease-causing transcriptional programs in cancer, today announced the appointment of Dr. Michael Bauer as Chief Executive Officer (CEO), effective May 1, 2023.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding QUANTRO Therapeutics
QUANTRO Therapeutics GmbH specializes in innovative cancer drug discovery by leveraging advanced technologies in functional genetics and transcriptomics. Their mission is to transform the precision and scope of cell-based compound screening through a unique drug discovery pipeline. The company aims to serve clients in the pharmaceutical and biotech... Read More